Design and evaluation of pyrazolopyrimidines as KCNQ channel modulators |
| |
Authors: | Augustine T Osuma Xiangdong Xu Zhi Wang Jennifer A Van Camp Gail M Freiberg |
| |
Institution: | Discovery, AbbVie Inc., North Chicago, IL 60064-6101, United States |
| |
Abstract: | Effective treatments of neuropathic pain have been a focus of many discovery programs. KCNQ (kv7) are voltage gated potassium channel openers that have the potential for the treatment of CNS disorders including neuropathic pain. Clinical studies have suggested agents such as Retigabine to be a modulator of pain-like effects such as hyperalgesia and allodynia. In this paper, we describe the discovery and evaluation of a series of novel pyrazolopyrimidines and their affinity for potassium channels KCNQ2/3. These pyrazolopyrimidines have also shown good efficacy in the capsaicin-induced acute and secondary mechanical allodynia model and excellent pharmacokinetic properties, which may be superior to Retigabine. |
| |
Keywords: | Corresponding author KCNQ Potassium channel Kv7 |
本文献已被 ScienceDirect 等数据库收录! |